About The Event
Join leading researchers, clinicians, and biotech industry experts for two days of rigorous scientific exchange dedicated to accelerating treatments and improving care for the Kleefstra syndrome (KS) community. This specialized track will dive deeply into the latest preclinical models, clinical trial readiness, and emerging therapeutic pipelines. Attendees will have the unique opportunity to collaborate on actionable roadmaps, share updates on cutting-edge gene and drug therapies, and explore new paradigms in biomarker discovery.